abstract |
The present invention relates to a compound of the formula I, which is used as an inhibitor of the microsomal prostaglandin E2 synthetase-1 (mPGES-1), a pharmaceutical composition thereof, and as a therapeutic and/or prophylactic inflammatory disease and Use of a medicament for a related condition. A, L, M, W, R1, R2, R3, R4, R6, R7, R9, Ra, Rb have the meanings given in the present specification. |